Clinical Trials Logo

Clinical Trial Summary

This study investigated the effectiveness of pravastatin on renal function in Korean dyslipidemic patients with Type 2 diabetes.


Clinical Trial Description

This survey study investigated the effect of routine initiation single dose of pravastatin (10 mg, 20 mg, or 40 mg) on renal function in Korean dyslipidemic patients with Type 2 diabetes. The study also examined the effect of pravastatin on lipid profiles, glucose metabolism, and safety. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05107063
Study type Observational
Source Daiichi Sankyo, Inc.
Contact
Status Completed
Phase
Start date January 20, 2016
Completion date April 19, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05563090 - Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
Completed NCT05072990 - Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
Completed NCT03932721 - EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial Phase 4
Terminated NCT03258281 - Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus Phase 4
Not yet recruiting NCT05128747 - Effectiveness of Nutritional Program Among Diabetic Patients N/A
Completed NCT05806723 - Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men Phase 4
Recruiting NCT04943926 - Dietary Strategies for Remission of Type 2 Diabetes N/A
Completed NCT03784703 - Type 2 Diabetic Patients Maintained on Statin Therapy Phase 4
Recruiting NCT04882293 - Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP. Phase 3
Recruiting NCT04602754 - Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia. Phase 3